Correction to: Adv Ther (2022) 39:3059–3060 10.1007/s12325-022-02060-1
In the article “Patterns of use and clinical outcomes with long-acting somatostatin analogs for neuroendocrine tumors: a nationwide French retrospective cohort study in the real-life setting” by Brooke Harrow, Francis Fagnani, Camille Nevoret, Xuan-Mai Truong Thanh, Marie de Zélicourt, and Louis de Mestier (Advances in Therapy, 2022, Vol. 39, No. 4, pp. 1754–1771. 10.1007/s12325-022-02060-1) there was an error in the caption of Fig. 3 and in the fifth paragraph of the Results as well as in the accompanying infographic summary.
The values for median time to second-line treatment for patients with GEP-NETs receiving lanreotide autogel (LAN) versus octreotide long-acting release (OCT) were switched in the caption of Fig. 3. The correct value for median time to second-line treatment for patients receiving is: 80.9 months (95% CI: 69.9−97.0). The correct value for median time to second-line treatment for patients receiving OCT is: 98.7 months (95% CI: 65.8−NA). These values have been corrected within the caption of Fig. 3.
The fifth paragraph of the Results section, "Time to second-line treatment (GEP-NETs subgroup only)" reflected the error in the caption of Fig. 3. The paragraph has been corrected and now reads as follows:
In the GEP-NETs subgroup, there was no significant difference in time to second-line treatment, estimated from a Kaplan–Meier survival model, for patients in the LAN group compared with patients in the OCT group (LAN: 80.9 months [95% CI: 69.9–97.0] vs. OCT: 98.7 months [95% CI: 65.8–NA]; log–rank p value = 0.97; Fig. 3). The results remained non-significant even after adjusting for covariates (adjusted HR: 1.0 [95% CI: 0.9–1.2]). This analysis was not performed in the overall study population.
The figure displaying “Median time to second-line treatment” and corresponding footnotes in the infographic summary have likewise been adjusted, so that the value for LAN is 80.9 months (95% CI: 69.9–97.0) and the value for OCT is 98.7 months (95% CI: 65.8–NA).
The original article has been corrected.